JSF Financial, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1802224 LOS ANGELES, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,273,886

-$71,173 QoQ

Shares Held

10,083

+4.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.71%

of 13F equity value

Holder Rank

#977

of 2,266 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

JSF Financial, LLC holds $7,126,230 across 5 Drug Manufacturers - General names. GILD ranks #3 (17.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,239	$2,685,523
2	MRK	Merck & Co., Inc.	13,960	$1,793,860
3	GILD	Gilead Sciences, Inc. This page	10,083	$1,273,886
4	JNJ	Johnson & Johnson	3,320	$843,180
5	AMGN	Amgen Inc	1,463	$529,781

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,273,886	10,083	+4.5%	Shares	Sole	2026-07-28
2026-03-31	$1,345,059	9,651	-5.0%	Shares	Sole	2026-05-07
2025-12-31	$1,247,529	10,164	—	Shares	Sole	2026-02-04
No filing history on record for this holder in this stock.